ROCKWELL MEDICAL, INC. Deferred Revenue, Revenue Recognized (Deprecated 2016-01-31)
ROCKWELL MEDICAL, INC. (RMTI) reported Deferred Revenue, Revenue Recognized (Deprecated 2016-01-31) of $2.92 million for the 6-month period ending 2016-06-30, per its 10-Q filed 2016-08-09.
Discontinued › Income Statement › Other Income
us-gaap:DeferredRevenueRevenueRecognized · last filed 2016-08-09
- ROCKWELL MEDICAL, INC. deferred revenue, revenue recognized (deprecated 2016-01-31) for the quarter ending 2016-03-31 was $3.47M.
- ROCKWELL MEDICAL, INC. deferred revenue, revenue recognized (deprecated 2016-01-31) for the quarter ending 2015-03-31 was -$493.23K.
- ROCKWELL MEDICAL, INC. deferred revenue, revenue recognized (deprecated 2016-01-31) for fiscal 2015 was -$2.08M.
- ROCKWELL MEDICAL, INC. deferred revenue, revenue recognized (deprecated 2016-01-31) for fiscal 2014 was -$507.48K.
| Period end | Deferred Revenue, Revenue Recognized (Deprecated 2016-01-31) 3 month | Deferred Revenue, Revenue Recognized (Deprecated 2016-01-31) 6 month | Deferred Revenue, Revenue Recognized (Deprecated 2016-01-31) 9 month | Deferred Revenue, Revenue Recognized (Deprecated 2016-01-31) 12 month |
|---|---|---|---|---|
| 2016-06-30 | $2.92M 10-Q · filed 2016-08-09 | |||
| 2016-03-31 | $3.47M 10-Q · filed 2016-05-10 | |||
| 2015-12-31 | -$2.08M 10-K · filed 2016-02-29 | |||
| 2015-09-30 | -$1.48M 10-Q · filed 2015-11-09 | |||
| 2015-06-30 | -$986.45K 10-Q · filed 2016-08-09 | |||
| 2015-03-31 | -$493.23K 10-Q · filed 2016-05-10 | |||
| 2014-12-31 | -$507.48K 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |